Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior

Gene Therapy

Volumn 11, Issue 9, 2004, Pages 797-804

  Noordmans, A J ^a   Song, D K ^a   Noordmans, C J ^a   Garrity Moses, M ^b   During, M J ^c   Fitzsimons, H L ^c   Imperiale, M J ^d   Boulis, N M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adeno associated virus; Feeding; GABA; Glutamate decarboxylase; Hypothalamus

Indexed keywords

4 AMINOBUTYRIC ACID; BUFFER; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEIN; PHOSPHATE; SODIUM CHLORIDE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERROR; FECES; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MICROINJECTION; MOLECULAR PROBE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; STANDARD; STEREOTAXIC SURGERY; THALAMUS LATERAL NUCLEUS; TRANSCRIPTION REGULATION; URINE; VIRAL GENE DELIVERY SYSTEM; WEIGHT GAIN;

ADENOVIRIDAE; ANIMALS; EATING; FEEDING BEHAVIOR; GAMMA-AMINOBUTYRIC ACID; GENE TARGETING; GENE TRANSFER TECHNIQUES; GLUTAMATE DECARBOXYLASE; HYPOTHALAMIC AREA, LATERAL; MICROINJECTIONS; RATS; RATS, WISTAR; STEREOTAXIC TECHNIQUES; WEIGHT GAIN;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MARMOTA MONAX;

EID: 2442681583     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302223     Document Type: Article

References (35)

1. Wilson S et al. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96: 3211-3216.
2. Yoshimura N et al. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE). Urology 2001; 57 (Suppl 1): 116.
3. Muramatsu S et al. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes. Hum Gene Ther 2002; 13: 345-354.
4. During M et al. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Therapy 1998; 5: 820-827.
5. Sacchettoni S et al. Glutamate-modulated production of GABA in immortalized astrocytes transduced by a glutamic acid decarboxylase-expressing retrovirus. GLIA 1998; 22: 86-93.
6. Robert J et al. Adenovirus-mediated transfer of a functional GAD gene into nerve cells: potential for the treatment of neurological disease. Gene Therapy 1997; 4: 1237-1245.
7. Mi J et al. Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines. J Neurosci Res 1999; 57: 137-148.
8. During M et al. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 2001; 12: 1589-1591.
9. Luo J et al. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 2002; 298: 425-429.
10. Anand B, Brobeck J. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 1951; 24: 123-140.
11. Devor M et al. Physiological control of hypothalamically elicited feeding and drinking. J Comp Physiol Psychol 1970; 73: 226-232.
12. Valenstein E, Myslobodsky M. An inability of gamma-acetylenic GABA to block eating evoked by hypothalamic stimulation. Behav Brain Res 1980; 4: 343-349.
13. Kimura H, Kuriyama K. Distribution of gamma-aminobutyric acid (GABA) in the rat hypothalamus: functional correlates of GABA with activities of appetite controlling mechanisms. J Neurochem 1975; 24: 903-907.
14. Kelly J et al. GABA stimulation and blockade in the hypothalamus and midbrain: effects on feeding and locomotor activity. Pharmacol Biochem Behav 1977; 7: 537-541.
15. Rattan A, Mangat H. Electrical activity and feeding correlates of intracranial hypothalamic injection of GABA, muscimol and picrotoxin in the rats. Acta Neurobio Exp 1990; 50: 23-36.
16. Paxinos G, Watson C. Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press: New York, 1998.
17. Davidson B et al. Recombinant adeno-associated virus type 2, 4, 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428-3432.
18. Chamberlin N et al. Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res 1998; 793: 169-175.
19. Peel A, Klein R. Adeno-associated virus vectors activity and applications in the CNS. J Neurosci Methods 2000; 98: 95-104.
20. Summerford C, Samulski R. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
21. Boulis N et al. Adeno-associated viral gene expression in the adult rat spinal cord following remote vector delivery. Mol Ther 2000; 1: S110-S111.
22. Kaspar B et al. Targeted retrograde gene delivery for neuronal protection. Mol Ther 2002; 5: 50-56.
23. Klein R et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 2002; 176: 66-74.
24. Bankiewicz K et al. Convection-enhanced delivery of AAV vector in parkinsonian monkeys: in vivo detection of gene expression ad restoration of dopaminergic function using pro-drug approach. Exp Neurol 2000; 164: 2-14.
25. Sanchez-Pernaute R et al. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats. Mol Ther 2001; 4: 324-330.
26. Bartlett J, Samulski R, McCown T. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 1998; 9: 1181-1186.
27. McCown T et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99-107.
28. Tenenbaum L et al. Tropism of AAV-2 vectors for neurons of the globus pallidus. Neuro Rep 2000; 11: 2277-2283.
29. Xu R et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Therapy 2001; 8: 1323-1332.
30. Buckholtz NS et al. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. Neuropsychopharmacology 1990; 3: 137-148.
31. Harrison L, Kastin A, Zadina J. Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 1998; 19: 1603-1630.
32. Gupta RC, Patterson GT, Dettbarn WD. Mechanisms of toxicity and tolerance to diisopropylphosphorofluoridate at the neuromuscular junction of the rat. Toxicol Appl Pharmacol 1986; 84: 541-550.
33. Barnes E. Use-dependent regulation of GABAA receptors. Int Rev Neurobiol 1996; 39: 53-76.
34. Grimm D et al. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 9: 2745-2760.
35. Clark K et al. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detactable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031-1039.